Leading the Way in Life Science Technologies

GEN Exclusives

More »
GEN News Highlights

Related to MorphoSys Nabs Xencor’s Phase I B-Cell Malignancy Antibody for $13M Up Front

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »